AJP - Endo Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (September 27, 2005). doi:10.1152/ajpendo.00131.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/2/E308    most recent
00131.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, R.
Right arrow Articles by Oka, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, R.
Right arrow Articles by Oka, Y.
Submitted on March 22, 2005
Accepted on September 19, 2005

Cell-type specific activation of metabolism reveals that {beta}-cell secretion suppresses glucagon release from {alpha}-cells in rat pancreatic islets

Rui Takahashi1, Hisamitsu Ishihara1*, Akira Tamura1, Suguru Yamaguchi1, Takahiro Yamada1, Daisuke Takei1, Hideki Katagiri1, Hitoshi Endou1, and Yoshitomo Oka1

1 Division of Molecular Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan

* To whom correspondence should be addressed. E-mail: ishihara-tky{at}umin.ac.jp.

Abnormal glucagon secretion is often associated with diabetes mellitus. However, the mechanisms by which nutrients modulate glucagon secretion remain poorly understood. Paracrine modulation by {beta}- or {delta}-cells is among the postulated mechanisms. Herein we present further evidence of the paracrine mechanism. First, to activate cellular metabolism and thus hormone secretion in response to specific secretagogues, we engineered insulinoma INS-1E cells using an adenovirus-mediated expression system. Expression of the Na+-dependent dicarboxylate transporter (NaDC)-1 resulted in 2.5- to 4.6-fold (P < 0.01) increases in insulin secretion in response to various tricarboxylic acid cycle intermediates. Similarly, expression of glycerol kinase (GlyK) increased insulin secretion by a 3.8- or 4.2-fold (P < 0.01) in response to glycerol or dihydroxyacetone, respectively. This cell engineering method was then modified, using the Cre-loxP switching system, in order to activate {beta}-cells and non-{beta}-cells separately in rat islets. NaDC-1 expression only in non-{beta}-cells, among which {alpha}-cells are predominant, caused an increase (by 1.8-fold, P < 0.05) in glucagon secretion in response to malate or succinate. However, the increase in glucagon release was prevented when NaDC-1 was expressed in whole islets, i.e. both {beta}-cells and non-{beta}-cells. Similarly, an increase in glucagon release with glycerol was observed when GlyK was expressed only in non-{beta}-cells, but not when it was expressed in whole islets. Furthermore, dicarboxylates suppressed basal glucagon secretion by 30% (P < 0.05), when NaDC-1 was expressed only in {beta}-cells. These data demonstrate that glucagon secretion from rat {alpha}-cells depends on {beta}-cell activation, and provide insights into the coordinated mechanisms underlying hormone secretion from pancreatic islets.




This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
R. Takahashi, H. Ishihara, K. Takahashi, A. Tamura, S. Yamaguchi, T. Yamada, H. Katagiri, and Y. Oka
Efficient and controlled gene expression in mouse pancreatic islets by arterial delivery of tetracycline-inducible adenoviral vectors
J. Mol. Endocrinol., January 1, 2007; 38(1): 127 - 136.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.